In KEGG, we got 30 pathways enriched by upregulated DEGs, such as apoptosis, Parkinson's disease, diabetic cardiomyopathy, colorectal cancer, estrogen signaling pathway, and p53 signaling pathway (Figure 1(c)). This evidence concerns the gene TP53 and Parkinson disease.